Abstract
C-myc gene activation is a common event in multiple types of neoplasia and has been associated with different cellular processes relevant to the malignant transformation of cancer cells. C-myc gene amplification has been analysed in colorectal carcinomas by means of an innovative DNA fingerprinting method based on the arbitrarily primed PCR. This method requires a low amount of DNA, uses multiple internal controls and appears sensitive and reproducible. Clinicopathological and molecular correlates have been investigated in a series of 70 colorectal carcinomas. The incidence of c-myc amplification was 26%, ranging from two- to fivefold increase in copy number. C-myc amplification occurrence was more frequent in more advanced stages of tumour invasion (P < 0.001) and was associated with mutations in the p53 tumour-suppressor gene (P = 0.048). The presence of c-myc amplification was indicative of a shorter disease-free survival period but, because of its strong association with Dukes' stage, its prognostic value is questionable.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masramon, L., Arribas, R., Tórtola, S. et al. Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer. Br J Cancer 77, 2349–2356 (1998). https://doi.org/10.1038/bjc.1998.390
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.390
This article is cited by
-
Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis
Clinical & Experimental Metastasis (2016)
-
EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
British Journal of Cancer (2012)
-
pVHL-Mediated Transcriptional Repression of c-Myc by Recruitment of Histone Deacetylases
Molecules and Cells (2012)
-
Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc
BMC Cancer (2010)
-
Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells
Oncogene (2005)